Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Cancer Networks

22:15 EDT 23rd May 2018 | BioPortfolio

Here are the most relevant search results for "Cancer Networks" found in our extensive news archives from over 250 global news sources.

More Information about Cancer Networks on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Cancer Networks for you to read. Along with our medical data and news we also list Cancer Networks Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cancer Networks Companies for you to search.

Showing News Articles 1–25 of 341 from Cancer Networks

Wednesday 23rd May 2018

Salvage Cryoablation May Delay Hormone Therapy in Recurrent Prostate Cancer

Salvage prostate therapy following local recurrence post radiation may be a safe way to avoid or delay initiation of hormone deprivation.

Dabrafenib/Trametinib Approved for BRAF-Positive Anaplastic Thyroid Cancer

The approval is tremendous news and should have a profound impact on patients with the rare tumor, according to experts.

Secondary Surgery Associated With Improved Survival in Ovarian Cancer

A secondary cytoreductive surgery along with chemotherapy following recurrence in patients with epithelial ovarian cancer offered improved outcomes over treatment with chemotherapy alone.

Tuesday 22nd May 2018

Enzalutamide Benefit in Nonmetastatic CRPC?

A new analysis of PROSPER, presented at AUA 2018, suggests enzalutamide plus ADT may be superior to ADT alone in nonmetastatic CRPC.

Halt in Production of Codman Pump Leaves Questions

MSKCC’s Dr. Nancy Kemeny discusses the impact of a company's decision to halt manufacture of a pump used to treat liver mets from colon and rectal cancers.

Monday 21st May 2018

Misinformation Rampant Among Cancer Patients

Cancer patients get inundated with advice, how much of it can be trusted?

Cell-Free DNA Assay Can Help Monitor Melanoma for Metastasis

The presence and burden of single nucleotide variants as measured in cell-free DNA may have substantial prognostic utility in patients with melanoma who have metastases.

Friday 18th May 2018

“Screening Pill” Could Offer Noninvasive Breast Cancer Screening Method

Researchers have developed a “disease screening pill” that could allow for a noninvasive and safe method for detecting breast cancer using only near-infrared light.

Thursday 17th May 2018

‘Oral Chemo Starter Kits’ Boosted Safe Handling on Non-Oncology Units

After non-oncology units received comprehensive safety kits for handling oral hazardous drugs, chemo handling precautions at Maine Medical Center increased significantly.

Daily CHG Bathing Initiatives Reduced CLABSI

Detailed education and other initiatives related to CHG cloth use boosted bathing compliance rates by 95% in 14 months, and decreased CLABSI by 8%.

CBT, Acupuncture Combat Insomnia in Cancer Survivors

A study led by Dr. Jun Mao of MSKCC found CBT and acupuncture each yielded clinically meaningful and durable sleep-related QOL improvements.

Trabectedin Plus PLD Shows Benefit in Real-Life Ovarian Cancer Setting

Trabectedin plus pegylated liposomal doxorubicin offered clinical benefit in a real-life setting of patients with previously treated platinum-sensitive recurrent ovarian cancer.

Shorter-Duration Trastuzumab as Effective for HER2+ Early Breast Cancer

Women with HER2-positive early breast cancer achieved similar disease-free survival with 6 months of adjuvant trastuzumab compared with a 12-month duration, according to the phase III PERSEPHONE trial.

Wednesday 16th May 2018

Mathematical Modeling May Guide Cancer Treatment 'Holidays'

A Moffitt team suggests mathematical modeling may guide the optimal cancer treatment dosing approach better than MTD.

Auto HCT and Matched Sibling Transplant Effective in FL

While HCT is an important benefit for FL patients, the optimal approach remains up for debate.

Multi-epitope T-cell Vaccine Shows Promise in Ovarian, Breast Cancer

TPIV200 stimulates T cells to attack ovarian and triple negative breast tumor cells that over-express the folate receptor alpha protein.

Sarcopenia Predicts Tumor Recurrence Post Liver Transplantation?

Recurrence risk was greater in sarcopenic patients, and greater alpha-fetoprotein and microvascular invasion were independent risk factors.

ONS Role in New Guideline for irAE Management

In this podcast, Kelly Brassil, PhD, RN, discusses irAEs and ONS’s role in developing an ASCO/NCCN guideline for their management.

ONS Role in New Guidelines for irAE Management

In this podcast, Kelly Brassil, PhD, RN, discusses irAEs and ONS’s role in developing ASCO/NCCN guidelines for their management.

Duke Team Addresses Barriers to Oral Chemo

A streamlined nursing protocol reduced delays related to treatment with oral formulations of chemotherapy and immunotherapy, and increased patient satisfaction.

Tuesday 15th May 2018

Implications of Mutation Profiling in Myeloid Malignancies—PART 2: Myeloproliferative Neoplasms and Other Myeloid Malignancies

In this second part of our two-part review, we discuss the use of mutation profiling in the diagnosis, prognosis, and treatment of patients with myeloproliferative neoplasms and other myeloid diseases.

Robert Chapkin on Relationships Between the Gut Microbiome, Diet, and Colorectal Cancer

In this Q&A, we discuss the research into the relationships between gut microbiota, diet, and colorectal cancer.

Initiation of ADT in a Man With Locally Advanced Prostate Cancer and Multiple Cardiovascular Risk Factors

A 65-year-old man presented with locally advanced, high-risk prostate cancer. His medical history was remarkable for type 2 diabetes mellitus, and he was an active smoker with a 27 pack-year history.

Improving Adherence to Endocrine Therapy in Women With HR-Positive Breast Cancer

Here, we discuss how to improve adherence to endocrine therapy in women with HR-positive breast cancer, as well as the side effects and the reasons for discontinuation.

Combination Controversies: Checkpoint Inhibition Alone or in Combination for the Treatment of Melanoma?

In this review, we highlight prospective data on checkpoint inhibition alone and in combination, discuss data regarding the efficacy and toxicity of combination therapy, and identify clinical scenarios that may favor treatment with combination therapy.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks